Market Overview

FDA Posts Briefing Documents for J&J's Canagliflozin

Share:
Related JNJ
Here's Everything You Need To Know About Blue Chip Stocks
vTv Therapeutics Shares Initiated With Buy Rating, $13 Target
Intra-Cellular Catatonic After Schizophrenia Fail (Seeking Alpha)

View briefing document.

Posted-In: News

 

Related Articles (JNJ)

View Comments and Join the Discussion!